Arkolith/Insider Trading/ADPT/Form 4

Rubinstein Julie

President and COOAdaptive Biotechnologies Corp (ADPT) · full profile →Form 4 · filed Apr 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$758K
Net Open-Market Flow
-$758K
Transactions
14
10 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 13, 2026Sell(S)16K$12.95$204K425K
Apr 13, 2026Sell(S)3K$14.08$47K421K
Apr 13, 2026Option exercise(M)8K$7.27$59K434K
Apr 13, 2026Option exercise(M)7K$8.46$56K440K
Apr 10, 2026Option exercise(M)15K$7.27$107K445K
Apr 10, 2026Sell(S)19K$12.75$238K426K
Apr 10, 2026Sell(S)400$13.48$5K426K
Apr 9, 2026Option exercise(M)15K$7.27$107K449K
Apr 9, 2026Sell(S)17K$13.79$234K432K
Apr 9, 2026Sell(S)2K$14.44$30K430K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 13, 2026Option exercise(M)8K—$00
Apr 13, 2026Option exercise(M)7K—$0193K
Apr 10, 2026Option exercise(M)15K—$08K
Apr 9, 2026Option exercise(M)15K—$023K

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001780664-26-000024) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML